|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | ||||||||||||
| Cash | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Prepaid expenses and other current assets | ||||||||||||
| Total Current Assets | ||||||||||||
| Deferred equity issuance costs | ||||||||||||
| Total Assets | ||||||||||||
| Current Liabilities: | ||||||||||||
| Related party payables | ||||||||||||
| Accounts payable and accrued expenses | ||||||||||||
| Accounts payable - trade | ||||||||||||
| Accrued expenses | ||||||||||||
| Convertible notes payable, net of debt issuance costs and discounts | ||||||||||||
| Derivative liability arising from convertible notes payable | ||||||||||||
| Accrued interest | ||||||||||||
| Note payable - stockholder | ||||||||||||
| Note payable - Lucius Partners Opportunity Fund | ||||||||||||
| Related Party | ||||||||||||
| Total note payable - Lucius Partners Opportunity Fund | ||||||||||||
| Financing liability | ||||||||||||
| Total Current Liabilities | ||||||||||||
| Total Liabilities | ||||||||||||
| Stockholders’ Deficit: | ||||||||||||
| Common stock, $0.0001 par value; 50,000,000 shares authorized; 9,053,279 and 8,655,829 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total Stockholders’ Deficit | ||||||||||||
| Total Liabilities and Stockholders’ Deficit |
Loading...
